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Transplantation Compared with Matched Controls
Michelle M. Bishop,1 Stephanie J. Lee,2 Jennifer L. Beaumont,3 Michael A. Andrykowski,4
J. Douglas Rizzo,5 Kathleen A. Sobocinski,5 John R. Wingard1Little is known about the health promotion, prevention, and disease screening behaviors of cancer survivors
treated with hematopoietic cell transplantation (HCT), who undergo arduous treatment and may be at par-
ticular risk for late effects and secondary malignancies. The purposes of this study were to examine the cur-
rent health and secondary prevention behaviors of long-term HCT survivors compared with matched
controls without cancer, and to identify sociodemographic and clinical factors associated with appropriate
preventive practices. HCT survivors (n 5 662) were drawn from 40 North American transplantation cen-
ters. Peer-nominated acquaintances of survivors matched on sex, age, education, and marital status served as
controls (n 5 158). Data were collected a mean of 6.7 years post-HCT (range, 1.8-22.6 years). Despite
a greater frequency of physical exams, the HCT survivors had similar health and screening behaviors as
the matched controls. Sociodemographic factors were associated with health prevention behaviors in ex-
pected ways. Some differences between disease group and type of transplant were found, with survivors
of acute leukemia less likely to report regular exercise, autologous transplant survivors more likely than al-
logeneic transplant survivors to report screenings for breast and cervical cancer, and allogeneic transplant
survivors more likely than autologous transplant survivors to report undergoing a skin exam in the previous
year. Despite higher levels of engagement with health care providers, HCT survivors had similar health be-
haviors as matched controls and comparable to those reported by cancer survivors who did not undergo
HCT. There remains considerable room for improvement. These findings support the need for further ed-
ucation of both HCT survivors and health practitioners.
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6/j.bbmt.2009.09.015with 70% living 5 years or longer [1]. The rising num-
ber of cancer survivors means more individuals at in-
creased risk for cancer recurrence, secondary cancers,
and late effects of treatments [2]. Survivors of hemato-
poietic cell transplantation (HCT) are at particular risk
for adverse outcomes because of the intensity of the
conditioning regimen and complications of treatment
(eg, graft-versus-host disease [GVHD]) [3,4]. Engaging
in health promotion and disease prevention activities
could attenuate some of the secondary health problems,
as well as improve quality of life [5]. Although there is
a growing literature on the health behaviors of cancer
survivors, the prevalence of preventive health behaviors
in HCT survivors is largely unknown.
Surviving the rigors of HCT treatment might mo-
tivate survivors to protect their health. For some, can-
cer/HCT may serve as a ‘‘wake-up call’’ that life is
fragile and good health is not guaranteed, motivating
them to stop smoking or begin exercising. For others,
preventive health behaviors may be a way to maximize
posttreatment rehabilitation, recovery, and quality of207
208 Biol Blood Marrow Transplant 16:207-214, 2010M. M. Bishop et al.life, or as a way to exert control over one’s body during
a period in which little control is experienced. On the
other hand, fear of recurrence, desire to avoid medical
contact, or lack of financial resources or insurance cov-
erage could reduce the frequency of preventive health
practices.
Many cancer survivors do initiate exercise, diet, and
other healthful lifestyle changes after diagnosis [6].
Certain behavior changes, such as quitting smoking
and decreasing alcohol consumption, are more pro-
nounced in survivors with cancers related to those be-
haviors, such as lung cancer and head and neck cancer
[6]. Nonetheless, many cancer survivors continue to
smoke, to remain overweight or obese [6,7], and/or to
not engage in physical activity [7]. The health behavior
patterns in cancer survivors and controls are often
comparable [8,9]. The prevalence of cancer screening
may be somewhat higher in cancer survivors than in
those with no history of cancer [10], although rates
vary considerably.
It is possible that along with differences based on
cancer site, differences in treatment experience could
affect subsequent health behaviors. Compared with
conventional cancer treatments, the high-dose therapy
associated with HCT involves greater intensity and
higher risk, which could contribute to greater motiva-
tion on the part of HCT survivors to engage in healthy
behaviors. Conversely, the intensity of the treatment
could lead to greater physical or mental health impair-
ments that could interfere with a survivor’s ability or
motivation to engage in some health behaviors, such
as exercise. The survivor might feel so ‘‘lucky’’ to
have survived that he or she becomes less vigilant for
signs of a second cancer and other diseases. Nonethe-
less, most HCT survivors appear to have regular
follow-up with physicians, often for many years [3],
in contrast to adult survivors treated with conventional
therapy, as many as 60% of whom report no regular
medical follow-up [10]). This repeated contact of
HCT survivors with health providers should increase
the likelihood of regular screenings and opportunities
for education about health behaviors.
This is the first study to compare the health behav-
iors and secondary cancer screening rates in long-term
HCT survivors and matched acquaintance controls
without cancer. The goals of this cross-sectional study
were to (1) identify the prevalence of health behaviors,
screening rates, and other health practices in very-
long-term HCT cancer survivors compared with
matched noncancer controls and (2) identify sociode-
mographic and clinical factors associated with those
health behaviors. We hypothesized that HCT survi-
vors would be more likely than matched controls to en-
gage in healthy behaviors, cancer screenings, and good
health practices given the intensity of their treatment
and their ‘‘second chance at life.’’ We also investigated
for differences in behaviors based on cancer site, typeof transplant, time since transplantation, treatment in-
tensity, and presence of GVHD.METHODS
This report examines previously unpublished data
from a large multisite study comparing long-term
quality of life in cancer/HCT survivors and a subset
of matched peer-nominated controls. Data on the
quality of life of survivors compared with controls
was presented previously, as were details regarding
survivor characteristics, study procedures, and institu-
tional review board approval obtained from each par-
ticipant [11]. To be eligible for the study, a survivor
had to have undergone single allogeneic or autologous
HCT during adulthood for 1 of 4 diseases (acute leu-
kemias, chronic myelogenous leukemia [CML], lym-
phoma, and breast cancer), to have undergone HCT
at least 1 year previously, and to have been in continu-
ous remission since the transplantation.
Survivors were randomly selected from a stratified
list (by disease, type of transplant, time since transplan-
tation, and intensity of pre-HCT treatment) of eligible
survivors at 40 transplantation centers in North
America registered with the Center for International
Blood and Marrow Transplantation (CIBMTR).
Because the BMT population is predominantly Cauca-
sian, we oversampled African Americans, to increase the
ethnic diversity of the sample. A total of 2447 poten-
tially eligible survivors were identified from the
CIBMTR; 1946 of these were selected at random for
potential study enrollment. Of these, 262 had no avail-
able contact information and 295 were ineligible, most
because of death or disease relapse. Attempts were made
to reach the remaining survivors. Contact was made
with 960; of these, 118 declined participation and 138
provided verbal consent but did not return a consent
form. A potential participant who declined or was
unable to be contacted was replaced by the next person
on the randomized list. A total of 704 survivors (73.3%
of the eligible survivors successfully contacted) pro-
vided written consent. Of these, 42 were withdrawn
from the study for various reasons, including voluntary
withdrawal, study ineligibility, or loss to follow-up. Of
those who consented, 94% completed the study.
Controls were survivor acquaintances matched to
survivors on sex, age, education, and marital status,
with no history of cancer/HCT and no involvement
in providing care to the survivor. Of the study-eligible
matched acquaintances contacted, 90% participated in
the study. Data were collected between March 2000
and September 2002.
Study Measures
Self-reported study measures assessed survivors’
health and secondary prevention behaviors and other
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graphic characteristics, including health insurance
status. Data on disease and treatment factors and func-
tional status were extracted from CIBMTR registry
data. Participant groups completed identical measures.
Half of the measures were completed by hand, and the
other half were completed during computer-assisted
telephone interviews. Medical records were not re-
viewed to confirm self-reports.
Preventive Health Behaviors
A 30-item questionnaire was designed for the
study, based on recommended guidelines at the time.
Respondents were asked whether they underwent any
of the following procedures in the previous 12 months:
physical exam, cholesterol check, stool check, sigmoid-
oscopy or colonoscopy, blood pressure, eye exam, den-
tal exam, skin exam, and flu shot. Additional items for
female respondents included clinical breast exam,
mammogram, and pap smear, and those for male re-
spondents included prostate digital rectal exam and
prostate-specific antigen testing. Respondents also
were asked how often they currently smoked cigarettes
or a pipe or used chewing tobacco, drank more than 2
glasses of alcoholic beverages in a day, and exercised
moderately for 20 minutes at least 3 times a week,
with responses ranked on a Likert-type scale.
Sociodemographic Information
This information included age, race/ethnicity,
marital and occupational status, level of education,
and annual household income.
Disease and Treatment Information
This information included cancer diagnosis, previ-
ous cytotoxic treatment (less or more), and type of
transplant (allogeneic or autologous).
Physical Functioning
The SF-36 physical functioning subscale of the
SF-36 MOS12 was used to measure current physical
functioning.
Statistical Analyses
Survivors and controls were compared on age us-
ing a 2-sample t-test and on other categorical demo-
graphic characteristics using c2 tests. The c2 tests
were used to compare the prevalence of health behav-
iors and screening in survivors and controls. Logistic
regression models were used to adjust these compari-
sons for age, sex, and education. Within the survivor
group, screening and health behaviors were compared
between groups defined by sex, age, education, cancer
type, transplant type, and other demographic and clin-
ical variables. Examination of health behaviors was
a predefined exploratory aim of the project; no powercalculations were conducted for the exploratory end-
points. All tests were 2-sided, and no adjustments
were made for multiple comparisons.RESULTS
Details regarding participant identification and se-
lection were published previously, including a flow
chart summarizing recruitment of survivors [11]. In
terms of demographic characteristics, compared with
all nonparticipants (those lost to follow-up, unreach-
able, withdrawn from the study, passively declined,
or actively declined), participants were older (median
age, 42 vs 38 years; P\ .001), female (62% vs 52%;
P\ .001), and Caucasian (83% vs 71%; P\ .001).
However, when participants were compared only
with those who actively refused to participate, only de-
mographic differences in race/ethnicity remained
(83% of participants were Caucasian vs 68% of those
who actively refused participation; P\ .001).
In examining potential differences between partic-
ipants and nonparticipants on clinical characteristics,
we found the following. Compared with all nonpartic-
ipants (those lost to follow up, unreachable, withdrawn
from study, or passively or actively declined), partici-
pants were less likely to have lymphoma (20% vs
28%), more likely to have breast cancer (23% vs
18%; P\ .001), more likely to be in the early disease
status before pre-HCT treatment (61% vs 48%; P\
.001), more likely to have received an autologous
transplant (58% vs 29%), and less likely to have re-
ceived an allogeneic transplant (42% vs 71%; P \
.001). When participants were compared only with
those who actively refused participation, there were
no differences in terms of disease group (P 5 .12) or
disease status before HCT (P 5 .14). Participants
were more likely than active refusers to have received
an autologous transplant (58% vs 42%; P 5 .001).
Table 1 summarizes the demographic characteris-
tics of survivors and controls. The 2 groups were sim-
ilar, except that those in the survivor group were more
likely to be single, to have a lower income, and be less
educated. There were no differences between survivors
and controls in terms of having health insurance/med-
ical coverage and having a physician. Table 2 summa-
rizes the clinical characteristics of the survivor group.
Reported Health Behaviors, Health
Examinations, Cancer Screenings, and Influenza
Vaccination Practices of Survivors Compared
to Matched Controls
Table 3 gives the prevalence of reported health be-
haviors, health exams and cancer screenings, and influ-
enza vaccination practices in the past year in survivors
and controls. There was no difference in tobacco use
between survivors and matched controls. Survivors
Table 1. Demographic Characteristics for Survivors (n 5
662) and Matched Controls (n 5 158) and Survivor Clinical
Characteristics
Survivors Matched Controls
Age, years, median ± SD, range 49.1 ± 10.3, 21-77 50.1 ± 14.2, 27-76
Male 38% 30%
Married or partnered* 73% 87%
Caucasian 92% 95%
Education
# High school/GED 29% 19%
Some college/technical/AA 32% 32%
College degree or higher 39% 49%
Occupational status†
Working or student 73% 75%
Not working 15% 5%
Retired 11% 20%
Annual family income‡
< $40,000 33% 18%
$40,000-$80,000 39% 47%
> $80,000 28% 34%
Health insurance, % covered 96% 97%
Have a physician 98% 97%
Percentages shown represent the percentage of respondents with non-
missing data for that variable. Some percentagesmay not add up to 100%
because of rounding.
*P < .001.
†P < . 01.
‡P < .05.
Table 3. Reported Health Promotion Behaviors, Examina-
tions, Cancer Screenings, and Influenza Vaccination Practices
of Survivors Compared to Matched Controls
Survivors,
n (%)
Matched
Controls, n (%) P Value
Health promotion behaviors
How often do you smoke?
Never 555 (87) 133 (85) .547
Rarely, sometimes, often, always 82 (13) 23 (15)
How often do you drink more than 2 alcoholic beverages per day?
Never, rarely 542 (85) 117 (75) .003
Sometimes, often, always 96 (15) 36 (25)
How often do you exercise moderately for 20 minutes at least 3 times
a week?
Never, rarely, sometimes 407 (64) 86 (55) .046
Often, always 231 (36) 70 (45)
Engagement in all 3 health behaviors*
No 461 (72) 105 (67) .232
Yes 178 (28) 51 (33)
Body mass index
Underweight (BMI < 18.5) 19 (3) 3 (2) .586
Normal (BMI 5 18.5-24.9) 275 (45) 77 (51)
Overweight (BMI 5 25-29.9) 277 (45) 59 (39)
Obese (BMI $ 30) 45 (7) 12 (8)
Examinations and cancer screenings in the last 12 months
Physical exam
Yes 582 (91.08) 123 (80.39) .0018
No 57 (8.92) 30 (19.61)
Blood pressure check
Yes 614 (96.1) 138 (90.2) .0189
No 25 (3.9) 15 (9.8)
Dental exam
Yes 491 (76.96) 139 (90.85) .0001
No 147 (23.04) 14 (9.15)
Skin exam
Yes 302 (47.41) 55 (35.95) .011
No 335 (52.59) 98 (64.05)
Colorectal cancer screening (FOB, sigmoidoscopy, and/or colonoscopy, age
50+ only)
Yes 143 (47.04) 43 (57.33) .110
No 161 (52.96) 32 (42.67)
Breast cancer screening (CBE and/or mammogram, women aged 50-65 years
only)
Yes 132 (76.74) 37 (84.09) .292
210 Biol Blood Marrow Transplant 16:207-214, 2010M. M. Bishop et al.were less likely than controls to engage in regular exer-
cise and to report drinking alcohol (Table 3). No
group differences on reports of engaging in all 3
healthy behaviors were found. Body mass index
(BMI) was similar in the 2 groups.
Compared with controls, survivors were more
likely to have had a physical exam (P 5 .002), a blood
pressure check (P5 .02), and a skin exam (P5 .01), but
less likely to have had a dental exam (P5 .0001). Can-
cer screening behaviors were similar in the 2 groups,Table 2. Clinical Characteristics of Survivors (n 5 662)
Time since HCT, years Mean, 7.0 ± 3.1; median,
6.6; range, 1.8-22.6
Type of transplant, n (%)
Allogeneic HCT 272 (41%)
Autologous HCT 390 (59%)
Malignant disease at initial diagnosis, n (%)
Acute leukemia* 243 (37%)
Breast cancer 156 (24%)
Hodgkin/non-Hodgkin lymphoma 132 (20%)
CML 131 (20%)
Intensity of pre-HCT cytotoxic treatment, n (%)†
Less intense 441 (67%)
More intense 221 (33%)
Allogeneic HCT survivors with cGVHD, n (%) 83 (40%)
HCT indicates hematopoietic cell transplantation; cGVHD, chronic
graft-versus host disease; CML, chronic myelogenous leukemia.
Some percentages may not add up to 100% because of rounding.
*Includes acute myelogenous leukemia and acute lymphocytic leukemia.
†The less intense treatment group included patients undergoing HCT for
chronic-phase CML within 1 year of diagnosis, for acute leukemia or lym-
phoma in first complete remission, and for adjuvant treatment of high-risk
stage II or III breast cancer. The more intense treatment group included
those undergoing HCT for chronic-phase CML > 1 year after diagnosis,
for accelerated or blast-phase CML, for acute leukemia or lymphoma
beyond first remission, and for metastatic breast cancer.
No 40 (23.26) 7 (15.91)
Pap smear (women only)
Yes 292 (72.64) 90 (82.57) .034
No 110 (27.37) 19 (17.43)
Prostate cancer screening (digital rectal exam and/or prostate-specific
antigen, men aged 50+ years only)
Yes 72 (62.61) 20 (80.00) .097
No 43 (37.39) 5 (20.00)
All suggested screening (listed above) for age/sex
Yes 105 (16.43) 31 (19.87) .306
No 534 (83.57) 125 (80.13)
Vaccinations in the last 12 months
Influenza vaccination†
Yes 381 (59.72) 50 (32.68)‡ < .001
No 257 (40.28) 103 (67.32)
Numbers may not add up because of missing data.
*Defined as never smoking, never or rarely drinking alcohol, and often
or always engaging in exercise.
†Because of varying physician preferences regarding immunizations in
patients with active GVHD, the 83 survivors who reported having active
GVHD were excluded.
‡73% of controls over the age of 65 years and 95% of survivors over the
age of 65 years reported having received the influenza vaccine (P5.072).except that survivors were less likely to have had
a pap smear (P 5 .034). Survivors were more likely
to have had the influenza vaccine than all controls
Table 4. Health Behaviors of Survivors by Sex, Age, and Educational Status
Smoking, % (95% CI) Drinking % (95% CI) Exercising, % (95% CI)
Male 16.7 (12.1-22.1) 20.1 (15.2-25.8) 36.3 (30.2-42.8)
Female 10.7 (7.8-14.1) 12.1 (9.1-15.7) 36.1 (31.4-41.0)
P .03 .007 .96
Age (years)
20-39 15.91 (10.1-23.3) 15.2 (9.5-22.4) 34.9 (26.8-43.6)
40-59 13.47 (10.3-17.2) 15.92 (12.5-19.9) 35.3 (30.6-40.2)
> 60 6.73 (2.8-13.4) 11.54 (6.1-19.3) 41.4 (31.8-51.4)
P .04 .48 .33
Education
# High school/GED 17.11 (12.0-23.3) 14.9 (10.1-20.8) 85.11 (79.2-89.9)
Some college 12.44 (8.2-17.8) 16.9 (12.0-22.8) 83.08 (77.2-88.0)
$ College degree 9.35 (6.0-13.7) 13.8 (9.8-18.8) 86.18 (81.2-90.2)
P .02 .78 .0001
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whom the vaccine is recommended).Sociodemographic Factors Associated
with Survivor Health Behaviors
In bivariate analyses, survivors who were male,
younger, and had less education were more likely to re-
port smoking than survivors who were female, older,
and more educated (Table 4). In both univariate and
multivariate analyses, male survivors were more likely
to report drinking than female survivors (males, odds
ratio [OR] 5 2.33; 95% confidence interval [CI] 5
1.56-3.45; P\ .0001). Survivors with more education
were more likely to report exercising than those
with less education, whereas sex and age made no
difference.
In multivariate analyses, male sex, younger age,
and less education were independently associated
with smoking (males: OR 5 1.56, 95% CI 5 0.41-
0.98, P 5 .051; younger age: OR 5 0.74 per 10 years,
95% CI 5 0.62-0.89, P 5 .002; those with less educa-
tion: OR 5 1.38 for high school/GED or less [95%
CI 5 0.83-2.28], OR 5 0.61 for college degree or
higher [95% CI5 0.36-1.04], P5 .01). There were no
group differences in tobacco or alcohol use (survivor vs
control) after adjusting for sex, age, and education
(P 5 .31 and .057, respectively). Age and education,
as well as greater physical functioning, were related
to physical activity levels; that is, the survivors who
were more likely to engage in physical exercise were
older (OR 5 1.20 per 10 years; 95% CI 5 1.03-1.40;
P\ .02), more educated (OR5 1.57 for college degree
or higher, 95% CI 5 1.10-2.23; OR 5 0.82 for HS/
GED or less, 95% CI 5 0.55-1.23; P 5 .001), and re-
ported greater physical functioning (score of . 85 on
the SF 36 subscale: OR 5 3.10; 95% CI 5 2.24-
4.27; P\ .0001). The difference in reported exercise
behavior among survivors and controls found in uni-
variate analyses were no longer significant after adjust-
ing for sex, age, education, and physical functioning
(P 5 .63).Thus, after adjusting for age, sex, and education
(and physical functioning for exercise behaviors), the
estimated prevalence of the health behaviors of survi-
vors and controls were as follows: tobacco use, 12%
versus 15% (95% CI 5 10%-15% and 10%-23%, re-
spectively); physical activity, 34% versus 32% (95%
CI 5 31%-38% and 25%-40%, respectively); alcohol
use, 14% versus 25% (95% CI5 12%-17% and 19%-
33%, respectively).Disease and Treatment Factors Associated
with Survivor Health Behaviors
No relationship was found between survivor-
reported health behaviors (smoking, alcohol use, and
exercise) and the number of years since HCT, amount
of pre-HCT cytotoxic treatment (less vs more), or
type of transplant (allogeneic vs autologous). Within
the subset of allogeneic survivors, those with cGVHD
were less likely to smoke (P\ .03). Survivors of acute
leukemia were less likely to report engaging in regular
exercise compared with survivors of CML, lym-
phoma, and breast cancer (P # .04) and less likely to
engage in all 3 health behaviors (smoking, alcohol
use, and exercise) compared with all other groups
(P\ .03) (Table 5).Disease and Treatment Factors Associated
with Screening Practices of Survivors
Table 6 presents differences in reported cancer
screening behaviors by disease group and type of trans-
plantation. Autologous transplantation survivors were
more likely than allogeneic transplantation survivors
to report screenings for breast and cervical cancer,
which was not solely accounted for by a breast cancer
diagnosis. Allogeneic transplantation survivors were
more likely to report having undergone a skin exam
in the last year (P 5 .004).
With regard to the intensity of pretransplantation
therapy, survivors who received less intensive therapy
were more likely to report having had a physical
exam in the last year (P5 .045), but less likely to report
Table 5. Survivor Health Behaviors by Disease Group (n 5 662)
Acute Leukemia CML Lymphoma Breast Cancer P Value
How often do you smoke?
Never 202 (86.3%) 107 (85.6%) 111 (86.0%) 135 (90.6%) .545
Rarely.always 32 (13.7%) 18 (14.4%) 18 (14.0%) 14 (9.4%)
How often do you drink more than 2 alcoholic beverages per day?
Never, rarely 199 (85.0%) 106 (84.8%) 111 (86.0%) 126 (84.0%) .972
Sometimes.always 35 (15.0%) 19 (15.2%) 18 (14.0%) 24 (16.0%)
How often to you exercise moderately for 20 minutes at least 3 times a week?
Often, always 68 (29.1%) 49 (39.2%) 51 (39.5%) 63 (42.0%) .037†
Never.sometimes 166 (71.9%) 76 (60.8%) 78 (60.5%) 87 (58.0%)
All 3 healthy behaviors?*
Yes 50 (21.4%) 35 (27.8%) 43 (33.3%) 50 (33.3%) .028‡
No 184 (78.6%) 91 (72.2%) 86 (66.7%) 100 (66.7%)
*Defined as never smoking, never or rarely drinking alcohol, and often or always engaging in exercise.
†Pairwise comparisons: acute leukemias versus CML, P 5 .051; acute leukemias versus lymphoma, P 5 .042; acute leukemias versus breast cancer, P 5
.009.
‡Pairwise comparisons: acute leukemias versus CML, P 5 .172; acute leukemias versus lymphoma, P 5 .012; acute leukemias versus breast cancer, P 5
.009.
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pared with survivors who received more intensive ther-
apy. No other differences related to the intensity of
treatment were found.DISCUSSION
This is the first study to examine the health and
cancer screening behaviors of long-term cancer/
HCT survivors compared with matched noncancer
controls. Contrary to our hypothesis, and despite their
more frequent physical exams and good access to
health care, for the most part these survivors engaged
in preventive health practices no more frequently
than matched controls (and in some cases less fre-
quently). These results are somewhat surprising given
the ‘‘second chance at life’’ afforded these survivors and
their increased risk of late effects and second cancers
because of the high-dose therapy associated with
HCT.
With regard to health behaviors, the smoking and
alcohol consumption rates reported by the survivors inTable 6. Survivor Health Examinations and Cancer Screening Beh
Acute leukemias, CML, Lym
n (%) n (%)
Physical exam 209 (89) 116 (92) 1
Eye exam 156 (67) 92 (73)
Skin exam 111 (47) 72 (58)
Colorectal cancer screening (aged 50+ years only) 37 (42) 23 (43)
Breast cancer screening (women aged 50-65 years) 27 (71) 17 (61)
Pap smear (women) 81 (63) 50 (74)
Prostate cancer screening (men aged 50+ years) 23 (49) 18 (78)
All suggested screenings 32 (14) 28 (22)
NA, indicates not applicable; CML, chronic myelogenous leukemia.
We acknowledge that mammograms may be indicated for some HCT survivors
controls, we report only on those women aged 50-65 years who reported br
*Pairwise comparisons: breast cancer versus acute leukemias, P 5 .074; breast
†Pairwise comparisons: breast cancer versus acute leukemias, P5 .012; breastour study were similar to those reported previously by
other cancer survivors [6]. The physical activity rate
reported by survivors in this study (34%) was lower
than the rates reported in some studies of cancer survi-
vors (42%-83%) [5,6,8], although population-based
studies have found that only 22% of cancer survivors
are physically active [7], and some 75% of survivors
are not complying with physical activity recommenda-
tions [8]. Given that physical activity rates and body
weight are increasingly recognized as important risk
factors for poorer outcomes in cancer survivors [13],
attention to this area is merited. The secondary cancer
screening rates in our study were similar to those in
other studies of cancer survivors; however, in contrast
to other studies [8,14], we did not find these rates to be
better than those in noncancer controls. This may re-
sult from the fact that the survivors and controls in this
study were primarily Caucasian, well educated, and
fairly affluent.
We found that autologous HCT survivors are
more likely than allogeneic HCT survivors to report
breast and cervical cancer screenings in the past year,
who were more likely to have received a skin exam.aviors by Disease Group and Type of Transplant (n 5 662)
phoma, Breast cancer, Allogeneic HCT, Autologous HCT,
n (%) n (%) P Value n (%) n (%) P Value
11 (86) 146 (97) .006 240 (92) 342 (91) .519
84 (65) 96 (64) .409 183 (70) 245 (65) .161
48 (38) 71 (47) .017 141 (54) 161 (43) .004
32 (44) 51 (57) .144 38 (43) 105 (49) .329
20 (77) 68 (85) .051* 28 (61) 104 (83) .003
47 (81) 114 (77) .027† 94 (66) 198 (77) .021
31 (72) NA .020 22 (54) 50 (69) .093
18 (14) 27 (18) .157 46 (18) 59 (16) .499
under the age of 50 years; however, for the purpose of comparison with
east cancer screenings.
cancer versus CML, P 5 .007; breast cancer versus lymphoma, P 5 .737
cancer versus CML, P5 .577; breast cancer versus lymphoma, P5 .531.
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vivors have different expectations for posttransplanta-
tion outcomes. Allogeneic HCT survivors may expect
the treatment to be curative and the risk of second can-
cers to be small, whereas autologous HCT survivors,
aware that the risk of recurrence is fairly high, may
be more likely to screen for second cancers. The
greater frequency of skin examinations reported by al-
logeneic HCT survivors could reflect their vigilance
for signs of GVHD rather than a focus on skin cancer.
Alarmingly, although the reported influenza vaccina-
tion rate was greater in the HCT survivors than in
the controls, it should have been higher than 60%
given these patients’ ‘‘at risk’’ status [15].
Our finding of poorer than expected and desired
health behaviors in HCT survivors may reflect a lack
of education and/or understanding about survivorship
issues, such as the need for continued surveillance for
second cancers and engagement in healthy behaviors
to reduce late effects, decrease the risk of other dis-
eases, and improve quality of life. Previous studies
have noted that nearly half of cancer survivors are un-
aware of their increased risk for second cancers [8]. Of
course, perceived risk alone is not sufficient to induce
behavioral change. Perceived susceptibility, control,
and self-efficacy—constructs described in the Health
Belief Model [16] and other models of behavioral
change—may be necessary as well. Future studies
should examine the perceptions of risk, as well as
causal attributions and beliefs regarding the effective-
ness of screenings and health behaviors in attenuating
these risks.
Given that the survivors in our sample were more
likely than controls to have undergone a physical
exam, but generally no more likely to have engaged
in healthy behaviors or received cancer screenings
and influenza vaccinations, it is possible that the survi-
vors’ physicians also were unaware of their need for
a different pattern of care. Studies suggest that as few
as 20% of providers talk with cancer survivors about
health behaviors [6], and that only 10% of survivors re-
port that their physicians talk to them about smoking,
exercise, and diet [17]. Gaps in preventive care may be
related to type of provider. Primary care physicians
provide health care for an increasing number of adult
long-term survivors of HCT [3], and although guide-
lines exist for recommended screening and preventive
practices for long-term HCT survivors [18,19], some
primary care providers (PCPs) may not be aware of
these. There is evidence that PCPs are less likely to
screen their patients for second cancers than oncolo-
gists, who may be less likely to engage in non–cancer-
related preventive services [20,21]. Survivors who see
both types of providers tend to receive more services
[21]. The Institute of Medicine’s report on cancer sur-
vivorship cites many shortfalls in the posttreatment
health and preventive care of cancer survivors high-lighted by our results, and recommends the use of tran-
sition care plans to help address these issues [22].
However, one could argue that health behavior recom-
mendations should be incorporated into a patient’s
care from the moment of diagnosis, with the goal of
maximizing physical stamina and general health to
both withstand treatment and maintain maximal
health through survivorship. In fact, there may be
a window of opportunity around the time of diagnosis
(within 6 months) when health issues are most salient
for patients and the motivation to live and live well is
at its peak [23].
Our study has several limitations. The cross-
sectional design and unknown prediagnosis behaviors
make it impossible to determine whether health prac-
tices changed as a result of the diagnosis and treatment.
However, the similarities between the reported behav-
iors of survivors and matched controls suggest that
changes in health behaviors did not occur as a result
of the cancer/HCT. Unfortunately, there were no
standardized measures of health and screening behav-
iors at the time of the study, and so we developed our
own, making cross-study comparisons difficult. A par-
ticular limitation of our measure is that it asked about
health screening behaviors in the past year, even
though some recommendations are for less than yearly
exams (eg, Pap smears are recommended every 1-3
years). Guidelines for recommended health behaviors
have undergone recent changes that may affect the ap-
plicability of these time frames to the health behaviors
of current and future long-term HCT survivors. The
development of standardized questionnaires for health
behaviors and screenings (including dietary behaviors,
which we did not address) would be an asset to this area
of study, albeit challenging to accomplish as recom-
mendations change over time.
Additional limitations of the study are that our
sample was predominantly Caucasian (which reflects
the ethnic makeup of the BMT patient population as
a whole) and that Caucasians were more likely to par-
ticipate in the study than non-Caucasians, which limits
the generalizabilty of the results to non-Caucasians.
These 2 issues are particularly important, because
other studies have shown differences in health behav-
iors related to race/ethnicity. Although we used ran-
domization of eligible survivors in an attempt to
obtain the most representative sample possible, we
did find other differences between participants and
nonparticipants. Compared with all nonparticipants,
the participants were slightly older, more likely to be
female, less likely to have had lymphoma, and more
likely to have had breast cancer, more likely to be in
early disease (than intermediate or advanced) before
pre-HCT treatment, and more likely to have received
an autologous transplant. But, none of these differ-
ences were found when comparing participants to
those who actively refused study participation, except
214 Biol Blood Marrow Transplant 16:207-214, 2010M. M. Bishop et al.that participants were more likely to have received an
autologous transplant. Further studies are needed to
address these potential shortcomings.
Taken as a whole, our findings indicate that the
experience of cancer along with the intense HCT
treatment apparently does not result in significantly
improved health behaviors and screening practices af-
ter treatment. Although many of the health behaviors
and screening rates reported in the HCT survivors
were comparable to those reported by cancer survivors
in other studies, there remains considerable room for
improvement. Health promotion and lifestyle inter-
ventions to optimize health during and after cancer
treatment are necessary to effectively manage, treat,
and prevent comorbidities. Education of providers,
survivors, and family caregivers is needed. To maxi-
mize the effectiveness of this teaching, it should begin
shortly after diagnosis.ACKNOWLEDGMENTS
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